Patent Assignment
Reel/Frame 069461/0096
Change of Name
Recorded: 2024-11-27
Pages: 3
Assignor
BIOGEN HEMOPHILIA INC.
Executed: 2016-09-01
Assignee
BIOVERATIV THERAPEUTICS INC.
225 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Properties
(2)
Factor Viii Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
Factor Viii Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
Application:
18/961,658 →
Publication:
US 2025/0195620
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.